Cook Medical Adds Division For Minimally Invasive ENT Products

The otolaryngology/head and neck surgery (OHNS) clinical division will initially focus on developing products for soft tissue repair, salivary gland disease, chronic sinusitis, vocal cord paralysis, obstructive sleep apnea, and interventional airway and esophageal procedures. The new division and several new products were unveiled today at the American Academy of Otolaryngology-Head and Neck Surgery conference in Washington, D.C.

"We started Cook OHNS to pioneer ways to provide patients with diseases affecting the head and neck with less traumatic alternatives to surgeries," Thomas Cherry, global leader for the OHNS division, said in a press release. "As we met with physicians, we heard loud and clear that they saw many opportunities for minimally invasive medical devices in this field."

The OHNS division is the company’s 10th clinical division. Its creation comes less than two months after Cook Medical announced it would curb expansion plans because of the medical device tax.

Related Content

Medtech Companies Should Reinvest in Communities, but U.S. Government in the Way

Regulation Will Paralyze Innovation, Says Cook Medical’s Kem Hawkins

Who’s ‘High-Fiving’ About the Device Tax?

—Jamie Hartford is the associate editor of MD+DI. Follow her on Twitter @readMED.